226 related articles for article (PubMed ID: 33470834)
1. Lung-RADS Version 1.1: Challenges and a Look Ahead, From the
Chelala L; Hossain R; Kazerooni EA; Christensen JD; Dyer DS; White CS
AJR Am J Roentgenol; 2021 Jun; 216(6):1411-1422. PubMed ID: 33470834
[TBL] [Abstract][Full Text] [Related]
2. Real-World Lung Cancer CT Screening Performance, Smoking Behavior, and Adherence to Recommendations: Lung-RADS Category and Smoking Status Predict Adherence.
Barbosa EJM; Yang R; Hershman M
AJR Am J Roentgenol; 2021 Apr; 216(4):919-926. PubMed ID: 32755178
[No Abstract] [Full Text] [Related]
3. The 10 Pillars of Lung Cancer Screening: Rationale and Logistics of a Lung Cancer Screening Program.
Fintelmann FJ; Bernheim A; Digumarthy SR; Lennes IT; Kalra MK; Gilman MD; Sharma A; Flores EJ; Muse VV; Shepard JA
Radiographics; 2015; 35(7):1893-908. PubMed ID: 26495797
[TBL] [Abstract][Full Text] [Related]
4. Understanding Lung-RADS 1.0: A Case-Based Review.
Godoy MCB; Odisio EGLC; Erasmus JJ; Chate RC; Dos Santos RS; Truong MT
Semin Ultrasound CT MR; 2018 Jun; 39(3):260-272. PubMed ID: 29807636
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer screening by nodule volume in Lung-RADS v1.1: negative baseline CT yields potential for increased screening interval.
Silva M; Milanese G; Sestini S; Sabia F; Jacobs C; van Ginneken B; Prokop M; Schaefer-Prokop CM; Marchianò A; Sverzellati N; Pastorino U
Eur Radiol; 2021 Apr; 31(4):1956-1968. PubMed ID: 32997182
[TBL] [Abstract][Full Text] [Related]
6. Lung-RADS: Pushing the Limits.
Martin MD; Kanne JP; Broderick LS; Kazerooni EA; Meyer CA
Radiographics; 2017; 37(7):1975-1993. PubMed ID: 29053407
[TBL] [Abstract][Full Text] [Related]
7. Performance of ACR Lung-RADS in a clinical CT lung screening program.
McKee BJ; Regis SM; McKee AB; Flacke S; Wald C
J Am Coll Radiol; 2015 Mar; 12(3):273-6. PubMed ID: 25176499
[TBL] [Abstract][Full Text] [Related]
8. Implications of the updated Lung CT Screening Reporting and Data System (Lung-RADS version 1.1) for lung cancer screening.
Dyer SC; Bartholmai BJ; Koo CW
J Thorac Dis; 2020 Nov; 12(11):6966-6977. PubMed ID: 33282402
[TBL] [Abstract][Full Text] [Related]
9. Lung-RADS Category 3 and 4 Nodules on Lung Cancer Screening in Clinical Practice.
Mendoza DP; Petranovic M; Som A; Wu MY; Park EY; Zhang EW; Archer JM; McDermott S; Khandekar M; Lanuti M; Gainor JF; Lennes IT; Shepard JO; Digumarthy SR
AJR Am J Roentgenol; 2022 Jul; 219(1):55-65. PubMed ID: 35080453
[No Abstract] [Full Text] [Related]
10. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
[TBL] [Abstract][Full Text] [Related]
11. Update on ACR TI-RADS: Successes, Challenges, and Future Directions, From the
Hoang JK; Middleton WD; Tessler FN
AJR Am J Roentgenol; 2021 Mar; 216(3):570-578. PubMed ID: 33112199
[TBL] [Abstract][Full Text] [Related]
12. Outcomes From More Than 1 Million People Screened for Lung Cancer With Low-Dose CT Imaging.
Silvestri GA; Goldman L; Tanner NT; Burleson J; Gould M; Kazerooni EA; Mazzone PJ; Rivera MP; Doria-Rose VP; Rosenthal LS; Simanowith M; Smith RA; Fedewa S
Chest; 2023 Jul; 164(1):241-251. PubMed ID: 36773935
[TBL] [Abstract][Full Text] [Related]
13. Cancer Risk in Nodules Detected at Follow-Up Lung Cancer Screening CT.
Hammer MM; Byrne SC
AJR Am J Roentgenol; 2022 Apr; 218(4):634-641. PubMed ID: 34755524
[No Abstract] [Full Text] [Related]
14. Receipt of Recommended Follow-up Care After a Positive Lung Cancer Screening Examination.
Rivera MP; Durham DD; Long JM; Perera P; Lane L; Lamb D; Metwally E; Henderson LM
JAMA Netw Open; 2022 Nov; 5(11):e2240403. PubMed ID: 36326760
[TBL] [Abstract][Full Text] [Related]
15. ACR Lung-RADS v2022: Assessment Categories and Management Recommendations.
Christensen J; Prosper AE; Wu CC; Chung J; Lee E; Elicker B; Hunsaker AR; Petranovic M; Sandler KL; Stiles B; Mazzone P; Yankelevitz D; Aberle D; Chiles C; Kazerooni E
J Am Coll Radiol; 2024 Mar; 21(3):473-488. PubMed ID: 37820837
[TBL] [Abstract][Full Text] [Related]
16. Application of Lung-Screening Reporting and Data System Versus Pan-Canadian Early Detection of Lung Cancer Nodule Risk Calculation in the Alberta Lung Cancer Screening Study.
Tremblay A; Taghizadeh N; MacGregor JH; Armstrong G; Bristow MS; Guo LLQ; Lydell C; Pereira R; Lee A; Elliot T; MacEachern P; Graham A; Dickinson JA; Koetzler R; Lam SC; Yang H; Bédard EL; Tammemagi M; Burrowes P
J Am Coll Radiol; 2019 Oct; 16(10):1425-1432. PubMed ID: 31103442
[TBL] [Abstract][Full Text] [Related]
17. Lung Cancer Screening: Why, When, and How?
Fintelmann FJ; Gottumukkala RV; McDermott S; Gilman MD; Lennes IT; Shepard JO
Radiol Clin North Am; 2017 Nov; 55(6):1163-1181. PubMed ID: 28991558
[TBL] [Abstract][Full Text] [Related]
18. Lung-RADS Version 1.0 versus Lung-RADS Version 1.1: Comparison of Categories Using Nodules from the National Lung Screening Trial.
Kastner J; Hossain R; Jeudy J; Dako F; Mehta V; Dalal S; Dharaiya E; White C
Radiology; 2021 Jul; 300(1):199-206. PubMed ID: 33944631
[TBL] [Abstract][Full Text] [Related]
19. Lung cancer screening with MRI: Evaluation of MRI for lung cancer screening by comparison of LDCT- and MRI-derived Lung-RADS categories in the first two screening rounds.
Meier-Schroers M; Homsi R; Gieseke J; Schild HH; Thomas D
Eur Radiol; 2019 Feb; 29(2):898-905. PubMed ID: 29992387
[TBL] [Abstract][Full Text] [Related]
20. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
